Navigation Links
Georgia Ranks Fourth in the Number of Untreated HIV Patients in the United States

However, Georgia Remains a Difficult Target for Pharmaceutical Companies Wishing to Grow Their Patient Base, According to a New Analytics Tool From Decision Resources

WALTHAM, Mass., Jan. 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that despite being the ninth largest state, Georgia ranks fourth in the number of untreated HIV patients in the United States.

"HIV prevalence is linked to ethnic/racial demographics as well as to urban/rural variations -- Georgia's larger than average black population drives Georgia's high prevalence of HIV," stated Jason LaBonte, Ph.D., vice president of new product development at Decision Resources. "Our epidemiologic model predicts that eight out of 1,000 people in Georgia have the disease versus the national average of five out of 1,000."

The new analytics tool entitled PatientFinder: HIV estimates that this high prevalence is compounded by Georgia's lower than average treatment rate for the disease (ranked 28th in the United States) which leaves a large number of HIV patients without drug therapy. Despite the abundance of untreated patients, however, Georgia remains a difficult target for pharmaceutical companies wishing to grow their patient base. Only 82 percent of the state's population has prescription drug insurance, which ranks 37th in the U.S.

Why Pharmaceutical Companies Need this Information

With the type of information included in PatientFinder, pharmaceutical organizations can identify the local markets that offer the greatest opportunity for their branded drug. Companies can identify markets that are underserved and determine if they should increase direct-to-consumer advertising, work with the local managed care organizations to increase awareness of the disease and benefits of their drug or align sales representatives to maximize market potential.

About PatientFinder

PatientFinder is the only healthcare analytics tool that assesses local markets for expansion opportunity by determining the number of insured patients in each territory who have the disease but are untreated. PatientFinder covers each of the 50 U.S. states and 318 U.S. metropolitan statistical areas (MSAs) and provides:

  • Disease-specific prevalence numbers for each U.S. state and MSA
  • Examination of treatment rates for the disease population to create percent treated and percent untreated estimates by state and MSA
  • Unique analysis of the untreated population examined through a filter of prescription (Rx) benefit coverage. The end result is an estimate of how many patients are untreated but can afford therapy within each territory - the true local measure of opportunity for pharmaceutical companies

About Decision Resources

Decision Resources ( is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Natalia Morales                    Elizabeth Marshall
    Decision Resources                 Decision Resources, Inc.
    781-296-2691                       781-296-2563  

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
2. The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia
3. Georgia Pecans Fit!: New Campaign Highlights Health Benefits, Recipes, Web Site
4. SecureWorks Ranked 6th in Deloittes Technology Fast 50 Program for Georgia
5. MIT Holding, Inc. signs partnership agreement with Georgia Southern University
6. Coalition America, Inc. Again Named One of Georgias Fastest Growing Technology Companies in Deloittes Technology Fast 50 Program
7. Mismanagement at North Florida/South Georgia Veterans Health System Results in Chronic Staff Shortages, Budget Issues
8. Georgia Receives Second March of Dimes NICU Family Support(R) Project
9. U.S. News & World Report Names Kaiser Permanente Top-Ranked Health Plan in Georgia
10. Anti-smoking strategy targets fourth-graders, parents in rural and urban Georgia
11. Nationally-Recognized Georgia Diabetes Project Honored
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition has announced ... Multiple System Atrophy (MSA) research, timed today to coincide with Giving Tuesday 2015, a ... including their ability to work and be productive, to do simple daily activities like ...
(Date:12/1/2015)... ... December 02, 2015 , ... ClinicoEconomics and Outcomes Research ... of treatment for osteoporosis ”. , As corresponding author Dr Ankita Modi says ... with osteoporosis. Based on a large US managed care database, women aged 55 ...
(Date:12/1/2015)... ... December 01, 2015 , ... According to an ... has filed a discrimination claim against the U.S. Department of Health and Human Services, ... Care Act (ACA) plans are breaking the clause in the law prohibiting the denial ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of the ... named by MedEsthetics magazine as the Best Single Physician Practice in the nation. Dr. ... elite aesthetic physicians honored by the industry publication. , Dr. Vitenas said he ...
(Date:12/1/2015)... York, NY (PRWEB) , ... December 01, 2015 ... ... epidemic in the 1980s we have seen vast improvements in scientific research and ... made significant strides, providing increased hope and relief to those affected by HIV/AIDS. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015   MabVax Therapeutics Holdings, Inc . (OTCQB: ... has filed an Investigational New Drug Application (IND) with ... Company,s lead fully human antibody product HuMab 5B1 as ... to initiate the Phase I clinical trial early in ... The planned Phase I trial will evaluate the ...
(Date:12/1/2015)... FRANCISCO , Dec. 1, 2015  InCarda Therapeutics, ... development and commercialization of therapies for cardiovascular conditions via ... a subsidiary business in Australia . ... trial in Australia in the ... leading investigators and medical centers in Adelaide ...
(Date:12/1/2015)... , Dec. 1, 2015  The migration ... to develop shared care plans that help patients ... care plans will be digitally enabled, incorporate care ... needs and desires. They will also allow all ... patient,s health journey is optimal. That is the ...
Breaking Medicine Technology: